Literature DB >> 22670772

Cytosine-phosphate-guanosine-DNA induces CD274 expression in human B cells and suppresses T helper type 2 cytokine production in pollen antigen-stimulated CD4-positive cells.

S Kubo1, T Yamada, Y Osawa, Y Ito, N Narita, S Fujieda.   

Abstract

Co-stimulatory molecules are important for regulating T cell activation and immune response. CD274 [programmed death ligand 1 (PD-L1), B7-H1] has emerged as an important immune modulator that can block T cell receptor signalling. We have investigated whether PD-L1 and other co-stimulatory ligands could be expressed in human B cells stimulated by cytosine-phosphate-guanosine (CpG)-DNA. CpG-DNA strongly induced the co-inhibitory molecule ligand, PD-L1, of human B cells. Results show that nuclear factor-kappa B (NF-κB) signalling is involved directly in CpG-DNA-induced PD-L1 expression in human B cells. We sought to determine the effect of CpG-DNA-treated B cells on T helper type 2 (Th2) cytokine production in Cry j 1 (Japanese pollen antigen)-stimulated human CD4-positive cells from patients with seasonal allergic rhinitis caused by Japanese cedar pollen. CpG-DNA-treated B cells reduced Cry j 1-induced interleukin (IL)-5 and IL-13 production in CD4-positive cells. When the binding of PD-1 to PD-L1 was inhibited by PD-1-immunoglobulin (Ig), this chimera molecule reversed the previously described reductions in IL-5 and IL-13 production. In contrast, the CpG B-treated B cells increased both interferon (IFN)-γ and IL-12 production in the presence of Cry j 1-stimulated CD4-positive cells. CpG-DNA simultaneously reduced the expression of B7RP-1 [also known as inducible co-stimulator ligand (ICOSL), B7-H2] and the ligand of CD30 (CD30L). These results indicate that CpG-DNA induces co-inhibitory molecule ligand PD-L1 expression in human B cells and PD-L1 can suppress Th2 cytokine production in Cry j 1-stimulated CD4-positive cells, while CpG-DNA increased Th1 cytokine production and reduced the expression of co-stimulatory molecule ligands that can promote Th2 inflammatory responses.
© 2012 The Authors. Clinical and Experimental Immunology © 2012 British Society for Immunology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22670772      PMCID: PMC3390467          DOI: 10.1111/j.1365-2249.2012.04585.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

Review 1.  CD28/CTLA-4--CD80/CD86 and ICOS--B7RP-1 costimulatory pathway in bronchial asthma.

Authors:  Y-Q Chen; H-Z Shi
Journal:  Allergy       Date:  2006-01       Impact factor: 13.146

2.  The central role of CD30L/CD30 interactions in allergic rhinitis pathogenesis in mice.

Authors:  Takafumi Fuchiwaki; Xun Sun; Kenjiro Fujimura; Hisakata Yamada; Kensuke Shibata; Hiromi Muta; Eckhard R Podack; Hideyuki Kawauchi; Yasunobu Yoshikai
Journal:  Eur J Immunol       Date:  2011-08-30       Impact factor: 5.532

3.  Synthetic oligodeoxynucleotides inhibit IgE induction in human lymphocytes.

Authors:  S Fujieda; S Iho; Y Kimura; H Yamamoto; H Igawa; H Saito
Journal:  Am J Respir Crit Care Med       Date:  2000-07       Impact factor: 21.405

Review 4.  T-cell costimulatory molecules: optimal targets for the treatment of allergic airway disease with monoclonal antibodies.

Authors:  Richard Kroczek; Eckard Hamelmann
Journal:  J Allergy Clin Immunol       Date:  2005-10       Impact factor: 10.793

5.  Collaborative action of NF-kappaB and p38 MAPK is involved in CpG DNA-induced IFN-alpha and chemokine production in human plasmacytoid dendritic cells.

Authors:  Youko Osawa; Sumiko Iho; Rumiko Takauji; Hisakazu Takatsuka; Saburo Yamamoto; Takayuki Takahashi; Satomi Horiguchi; Yoshimasa Urasaki; Takasumi Matsuki; Shigeharu Fujieda
Journal:  J Immunol       Date:  2006-10-01       Impact factor: 5.422

6.  Platelet derived endothelial cell growth factor/thymidine phosphorylase enhanced human IgE production.

Authors:  Hideyuki Yamamoto; Takechiyo Yamada; Tetsuji Takabayashi; Hiroshi Sunaga; Myungmi Oh; Norihiko Narita; Akihiro Kojima; Shigeharu Fujieda
Journal:  Allergol Int       Date:  2011-01-25       Impact factor: 5.836

7.  Toll-like receptor 4 ligation enforces tolerogenic properties of oral mucosal Langerhans cells.

Authors:  Jean-Pierre Allam; Wen-Ming Peng; Torsten Appel; Matthias Wenghoefer; Bernd Niederhagen; Thomas Bieber; Stefaan Bergé; Natalija Novak
Journal:  J Allergy Clin Immunol       Date:  2007-11-26       Impact factor: 10.793

8.  CpG directly induces T-bet expression and inhibits IgG1 and IgE switching in B cells.

Authors:  Ningshu Liu; Noriko Ohnishi; Lin Ni; Shizuo Akira; Kevin B Bacon
Journal:  Nat Immunol       Date:  2003-05-25       Impact factor: 25.606

9.  CpG ODN mediated prevention from ovalbumin-induced anaphylaxis in mouse through B cell pathway.

Authors:  Wen Xu; Toshiki Tamura; Kiyoshi Takatsu
Journal:  Int Immunopharmacol       Date:  2007-11-20       Impact factor: 4.932

Review 10.  PD-1 and PD-1 ligands: from discovery to clinical application.

Authors:  Taku Okazaki; Tasuku Honjo
Journal:  Int Immunol       Date:  2007-07-02       Impact factor: 4.823

View more
  7 in total

1.  Soluble CD80 Protein Delays Tumor Growth and Promotes Tumor-Infiltrating Lymphocytes.

Authors:  Lucas A Horn; Tiha M Long; Ryan Atkinson; Virginia Clements; Suzanne Ostrand-Rosenberg
Journal:  Cancer Immunol Res       Date:  2017-11-09       Impact factor: 11.151

Review 2.  Immunosuppressive Mechanisms of Regulatory B Cells.

Authors:  Diego Catalán; Miguel Andrés Mansilla; Ashley Ferrier; Lilian Soto; Kristine Oleinika; Juan Carlos Aguillón; Octavio Aravena
Journal:  Front Immunol       Date:  2021-04-29       Impact factor: 7.561

3.  PD-L1+ Regulatory B Cells Are Significantly Decreased in Rheumatoid Arthritis Patients and Increase After Successful Treatment.

Authors:  Estefanía R Zacca; Luisina I Onofrio; Cristina D V Acosta; Paola V Ferrero; Sergio M Alonso; María C Ramello; Eduardo Mussano; Laura Onetti; Isaac I Cadile; Maria I Stancich; Maria C Taboada Bonfanti; Carolina L Montes; Eva V Acosta Rodríguez; Adriana Gruppi
Journal:  Front Immunol       Date:  2018-10-01       Impact factor: 7.561

Review 4.  Toll-Like Receptor Agonists as Adjuvants for Allergen Immunotherapy.

Authors:  Max E Kirtland; Daphne C Tsitoura; Stephen R Durham; Mohamed H Shamji
Journal:  Front Immunol       Date:  2020-11-12       Impact factor: 7.561

Review 5.  Regulatory B Cells and Its Role in Central Nervous System Inflammatory Demyelinating Diseases.

Authors:  Zhou Ran; Luo Yue-Bei; Zeng Qiu-Ming; Yang Huan
Journal:  Front Immunol       Date:  2020-08-20       Impact factor: 7.561

Review 6.  Allergen Immunotherapy: Current and Future Trends.

Authors:  Gandhi F Pavón-Romero; Maria Itzel Parra-Vargas; Fernando Ramírez-Jiménez; Esmeralda Melgoza-Ruiz; Nancy H Serrano-Pérez; Luis M Teran
Journal:  Cells       Date:  2022-01-08       Impact factor: 6.600

Review 7.  Regulatory B Cell Therapy in Kidney Transplantation.

Authors:  Sergio G Garcia; Noelia Sandoval-Hellín; Marcella Franquesa
Journal:  Front Pharmacol       Date:  2021-12-07       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.